Evidence map›Paper›PMID 29021438›Full record

Observational studyInternal medicine (Tokyo, Japan)2017

Factors for Predicting Outcomes among Non-HIV Patients with Pulmonary Tuberculosis.

Toshinori Tsukahara, Nobuyuki Horita, Ken Tashiro, Kenjiro Nagai, Masaharu Shinkai, Masaki Yamamoto, Takashi Sato, Yu Hara, Hideyuki Nagakura, Yuji Shibata and 10 more

Open access · diamondAbstract readObservational Study
In one paragraph

Observational study in Internal medicine (Tokyo, Japan), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Circulating antibody signatures againstFrontiers in immunology · 2026
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Toshinori TsukaharaDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, Japan.
Nobuyuki HoritaDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, Japan.
Ken TashiroDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, Japan.
Kenjiro NagaiDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, Japan.
Masaharu ShinkaiDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, Japan.
Masaki YamamotoDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, Japan.
Takashi SatoDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, Japan.
Yu HaraDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, Japan.
Hideyuki NagakuraDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, Japan.
Yuji ShibataDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, Japan.
Hiroki WatanabeDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, Japan.
Kentaro NakashimaDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, Japan.
Ryota UshioDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, Japan.
Akimichi NagashimaDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, Japan.
Misako IkedaDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, Japan.
Atsuya NaritaDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, Japan.
Katsuhito SasakiDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, Japan.
Nobuaki KobayashiRespiratory Disease Center, Yokohama City University Medical Center, Japan.
Makoto KudoRespiratory Disease Center, Yokohama City University Medical Center, Japan.
Takeshi KanekoDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, Japan.
Yokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective Onodera's Prognostic Nutritional Index (PNI), determined as "10× albumin (g/dL) + 0.005× lymphocyte count (/μL)," was originally designed to determine the risk of complications following gastrointestinal surgery. This single-center, retrospective observational study was designed to investigate whether or not the PNI can predict the treatment outcome. Methods We consecutively reviewed HIV-negative pulmonary tuberculosis adults in an isolation ward. Most patients were being treated with standard three- or four-drug regimens. Patients were discharged after consecutive negative smears/cultures were confirmed. The risk of all-cause death was assessed using a multivariable Cox proportional hazard model and a log-rank trend test. Results During the observation period, we observed 371 consecutive patients with a median age of 72 (interquartile range [IQR]: 54-82) years. In our cohort, 295 (79.5%) patients were discharged alive, and 76 (20.5%) died in-hospital. Patients who died in-hospital had a lower PNI [median 21.2 (IQR: 18.5-25.9)] than those who were discharged alive [median 35.1 (IQR: 28.0-43.3); p<0.001]. The area under the receiver operating characteristic curve was 0.87. After dividing the patients based on the baseline PNI quartile, those patients with a lower PNI showed a poorer survival than those with a higher PNI (log-rank trend p<0.001). After adjusting for other baseline variables, the baseline PNI was still associated with in-hospital death with a hazard ratio of 0.86 (95% confidence interval: 0.82-0.91, p<0.001). Conclusion Our results showed that a low PNI was clearly related to a poor survival prognosis in smear-positive HIV-negative pulmonary tuberculosis inpatients.

Indexed as

Nutrition AssessmentAgedAged, 80 and overAntitubercular AgentsFemaleHIV SeronegativityHospital MortalityHumansLymphocyte CountMaleMiddle AgedPrognosisRetrospective StudiesROC CurveTreatment OutcomeTuberculosis, PulmonaryAntitubercular Agentsantibioticsblood cell countcohort studynutritionpulmonary tuberculosis

Identifiers

PMID29021438
PMCPMC5790713
OpenAlexW2761720720

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.